Biologic drugs can be joint savers for rheumatoid arthritis (RA). But even these powerful medications don't always guarantee relief from pain and stiffness. Sometimes the first biologic you try ...

A handful of antibody-based extracellular targeted protein degraders are advancing in the clinic, highlighting emerging ...

The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to curb health costs. The ...

Psoriasis treatment has come a long way in the last 30 years. There’s no cure, but medication can help you gain control of your symptoms. If your current treatment doesn’t help enough, the doctor ...

FDA expands Dupixent approval for children aged 2 to 11 years with chronic spontaneous urticaria symptomatic despite H1 antihistamine use.

A drug that’s derived from living things and often administered by self-injection? Yeah, you’ve (understandably) got questions about biologic drugs—and we’ve got a handful you can go ahead and add to ...

Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous ...

Please provide your email address to receive an email when new articles are posted on . In recent years, we have made significant strides in our understanding of the pathogenesis of asthma. As a ...

Antibiotic exposure in psoriasis patients is linked to increased biologic therapy discontinuation, with risk rising with multiple courses, suggesting gut microbiota alterations may play a role. The ...

Biologic agents used for the treatment of rheumatic and immunological disorders can cause allergic adverse events (AEs), including standard infusion reactions and hypersensitivity reactions Biologic ...

The market for biologic drugs in the United States is large and growing. Total US biologic sales in 2018 is estimated to have been $125 billion, an increase of 50 percent since 2014. Given widespread ...